The East Africa generic drug market is currently witnessing moderate growth. Generic drugs are medications that contain the same active ingredients and have the same therapeutic effect as their branded counterparts. These drugs may differ in packaging but are identical in quality, strength, dosage, performance, and efficiency. As they are cost-efficient, the demand for generic drugs is escalating in the East African region.
The market is primarily driven by rapid urbanization, along with improving infrastructure and healthcare facilities in the East African region. Apart from this, governments of different countries in the region are introducing price control policies and import restrictions to encourage domestic drug manufacturing. This, in turn, is propelling the growth of the generic drugs market. However, the market experienced a negative impact on account of the sudden outbreak of the coronavirus disease (COVID-19), the imposition of lockdown restrictions, hindrances in international trade and a temporary halt in the operations of several manufacturing units. The market will witness growth once COVID-19 cases reduce, operations at these manufacturing units resume and lockdown relaxations are uplifted in the region. Looking forward, the market is expected to continue its moderate growth during the forecast period (2021-2026).
IMARC Group provides an analysis of the key trends in each sub-segment of the East Africa generic drug market report, along with forecasts for growth at the region level from 2021-2026. Our report has categorized the market based on region, segment, therapy area, drug delivery and distribution channel.
Breakup by Segment:
Breakup by Therapy Area:
Breakup by Drug Delivery:
Breakup by Distribution Channel:
Breakup by Country:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at